Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle cells and fibroblasts but little is known about its influence on growth in endothelial cells. We studied the effects of ANG II on endothelial growth and the role of the angiotensin receptor subtypes involved. Proliferation of rat coronary endothelial cells (CEC) and rat vascular smooth muscle cells (VSMC) was determined by [3H]thymidine incorporation, the MTT-test and by directly counting cells in a coulter counter. Angiotensin AT1- and AT2-receptors were demonstrated by binding studies and by the presence of their respective mRNA through reverse transcription polymerase chain reaction (RT-PCR). In contrast to VSMC, which in culture only express the AT1-receptor, CEC express both, AT1- and AT2-receptors simultaneously up to the third passage. Whereas ANG II stimulated growth of quiescent VSMC, an effect abolished by pretreatment with the AT1-receptor antagonist, losartan, ANG II did not induce proliferation in quiescent CEC. However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation. This effect was reversed by additional pretreatment with losartan. ANG II significantly inhibited the proliferation of bFGF-stimulated CEC in a dose-dependent manner by maximally 50%. This effect was prevented by PD 123177 while losartan was ineffective. The AT2-receptor agonist, CGP 42112, mimicked the antiproliferative actions of ANG II, confirming the specificity of the effect. Our results show that the growth modulating actions of ANG II depend on the type of angiotensin receptor present on a given cell. In coronary endothelial cells, the antiproliferative actions of the AT2-receptor offset the growth promoting effects mediated by the AT1-receptor.
M Stoll, U M Steckelings, M Paul, S P Bottari, R Metzger, T Unger
Title and authors | Publication | Year |
---|---|---|
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
C Doi, N Egashira, A Kawabata, DK Maurya, N Ohta, D Uppalapati, R Ayuzawa, L Pickel, Y Isayama, D Troyer, S Takekoshi, M Tamura |
BMC Cancer | 2010 |
Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases
EI Ager, WW Chong, SW Wen, C Christophi |
Cancer Cell International | 2010 |
Angiogenesis and Melanoma
D Ribatti, T Annese, V Longo |
Cancers | 2010 |
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases
L Shi, C Mao, Z Xu, L Zhang |
Drug Discovery Today | 2010 |
Telmisartan regresses left ventricular hypertrophy in caveolin-1 deficient mice
MH Krieger, AD Lorenzo, C Teutsch, K Kauser, WC Sessa |
Laboratory Investigation | 2010 |
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
NC Li, A Lee, RA Whitmer, M Kivipelto, E Lawler, LE Kazis, B Wolozin |
BMJ (Clinical research ed.) | 2010 |
Burger's Medicinal Chemistry and Drug Discovery
S Bruno, L Ronda, S Faggiano, S Bettati, A Mozzarelli |
Burger's Medicinal Chemistry and Drug Discovery | 2010 |
Textbook of Diabetes
PM Jones, SJ Persaud |
Textbook of Diabetes | 2010 |
Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis
M Sata, D Fukuda |
The Journal of Medical Investigation | 2010 |
Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium
T Hasin, O Elhanani, Z Abassi, T Hai, A Aronheim |
Basic Research in Cardiology | 2010 |
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?
T Dolley-Hitze, F Jouan, B Martin, S Mottier, J Edeline, O Moranne, PL Pogamp, MA Belaud-Rotureau, JJ Patard, N Rioux-Leclercq, C Vigneau |
British Journal of Cancer | 2010 |
Losartan Inhibits Vascular Smooth Muscle Cell Proliferation through Activation of AMP-Activated Protein Kinase
JE Kim, HC Choi |
The Korean Journal of Physiology and Pharmacology | 2010 |
The angiotensin AT2 receptor in left ventricular hypertrophy
UM Steckelings, RE Widdop, L Paulis, T Unger |
Journal of Hypertension | 2010 |
Fyn is involved in angiotensin II type 2 receptor-induced neurite outgrowth, but not in p42/p44mapk in NG108-15 cells
MO Guimond, C Roberge, N Gallo-Payet |
Molecular and Cellular Neuroscience | 2010 |
Liver regeneration and tumour stimulation: implications of the renin-angiotensin system
SL Koh, EI Ager, C Christophi |
Liver International | 2010 |
Changes in the renin angiotensin system during the development of colorectal cancer liver metastases
JH Neo, EI Ager, PW Angus, J Zhu, CB Herath, C Christophi |
BMC Cancer | 2010 |
Overexpression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells
L Pickel, T Matsuzuka, C Doi, R Ayuzawa, DK Maurya, SX Xie, C Berkland, M Tamura |
Cancer biology & therapy | 2010 |
Ethanol-induced downregulation of the angiotensin AT2 receptor in murine fibroblasts is mediated by PARP-1
M Menk, C Haefen, H Funke-Kaiser, M Sifringer, JH Schefe, S Kirsch, K Seidel, J Reinemund, UM Steckelings, T Unger, CD Spies |
Alcohol | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
Comprehensive Toxicology
JM Sands, JW Verlander |
Comprehensive Toxicology | 2010 |
xPharm: The Comprehensive Pharmacology Reference
A Vinh |
xPharm: The Comprehensive Pharmacology Reference | 2010 |
Burden of illness among patients at high risk versus low risk for major cardiovascular events
C Harley, SD Sander, V Zarotsky, F Cao, H Shah |
Journal of Medical Economics | 2010 |
Developmental changes in AT1 and AT2 receptor-protein expression in rats
L Yu, M Zheng, W Wang, GJ Rozanski, IH Zucker, L Gao |
Journal of Renin-Angiotensin-Aldosterone System | 2010 |
Skeletal muscle-endothelial cell cross talk through angiotensin II
LM Bellamy, AP Johnston, MD Lisio, G Parise |
American journal of physiology. Cell physiology | 2010 |
The Promyelocytic Leukemia Zinc Finger (PLZF) Protein Exerts Neuroprotective Effects in Neuronal Cells and is Dysregulated in Experimental Stroke: Neuroprotective Effects of PLZF
K Seidel, S Kirsch, K Lucht, D Zaade, J Reinemund, J Schmitz, S Klare, Y Li, JH Schefe, K Schmerbach, P Goldin-Lang, FS Zollmann, C Thöne-Reineke, T Unger, H Funke-Kaiser |
Brain Pathology | 2010 |